Clinical Trial Detail

NCT ID NCT02076997
Title Individualized High Dose Methotrexate to Treat Cancer in Children Who Have a Significant Risk for Side Effects to Methotrexate
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements no
Sponsors Baylor College of Medicine
Indications

hematologic cancer

Advanced Solid Tumor

Therapies

Methotrexate

Age Groups: child adult

No variant requirements are available.